FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Thomas Cook

Research Profile

Chemicals & Drugs

Disorders

Procedures

Concepts & Ideas

Physiology

Co-author Network

Publications

TOP 3
Claus G Roehrborn; John D McConnell; Brian Saltzman; Donald Bergner; Todd Gray; Perinchery Narayan; Thomas J Cook; Amy O Johnson-Levonas; Wilson A Quezada; Joanne Waldstreicher
Storage (irritative) and voiding (obstructive) symptoms as predictors of benign prostatic hyperplasia progression and related outcomes.
Claus G Roehrborn; M Malice; Thomas J Cook; CJ Girman
Clinical predictors of spontaneous acute urinary retention in men with LUTS and clinical BPH: a comprehensive analysis of the pooled placebo groups of several large clinical trials.
Steven A Kaplan; HL Holtgrewe; Reginald C Bruskewitz; Brian Saltzman; D Mobley; Perinchery Narayan; R H Lund; S Weiner; G Wells; Thomas J Cook; Alan G Meehan; Joanne Waldstreicher
Comparison of the efficacy and safety of finasteride in older versus younger men with benign prostatic hyperplasia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Thomas Cook (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2002: Claus G Roehrborn; John D McConnell; Brian Saltzman; Donald Bergner; Todd Gray; Perinchery Narayan; Thomas J Cook; Amy O Johnson-Levonas; Wilson A Quezada; Joanne Waldstreicher
Storage (irritative) and voiding (obstructive) symptoms as predictors of benign prostatic hyperplasia progression and related outcomes.
European urology 2002;42(1):1-6.
2001: Claus G Roehrborn; M Malice; Thomas J Cook; CJ Girman
Clinical predictors of spontaneous acute urinary retention in men with LUTS and clinical BPH: a comprehensive analysis of the pooled placebo groups of several large clinical trials.
Urology 2001;58(2):210-6.
2001: Steven A Kaplan; HL Holtgrewe; Reginald C Bruskewitz; Brian Saltzman; D Mobley; Perinchery Narayan; R H Lund; S Weiner; G Wells; Thomas J Cook; Alan G Meehan; Joanne Waldstreicher
Comparison of the efficacy and safety of finasteride in older versus younger men with benign prostatic hyperplasia.
Urology 2001;57(6):1073-7.
1999: Claus G Roehrborn; John D McConnell; Michael Lieber; S Kaplan; Jack Geller; Gholem H Malek; R Castellanos; S Coffield; Brian Saltzman; M Resnick; Thomas J Cook; Joanne Waldstreicher
Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. PLESS Study Group.
Urology 1999;53(3):473-80.
1998: Gerald L Andriole; Harry A Guess; Jonathan I Epstein; H Wise; Dov Kadmon; E D Crawford; P Hudson; C L Jackson; Nicholas A Romas; L Patterson; Thomas J Cook; Joanne Waldstreicher
Treatment with finasteride preserves usefulness of prostate-specific antigen in the detection of prostate cancer: results of a randomized, double-blind, placebo-controlled clinical trial. PLESS Study Group. Proscar Long-term Efficacy and Safety Study.
Urology 1998;52(2):195-201; discussion 201-2.